Chesi, Marta http://orcid.org/0000-0002-4024-8225
Mirza, Noweeda N
Garbitt, Victoria M
Sharik, Meaghen E
Dueck, Amylou C
Asmann, Yan W
Akhmetzyanova, Ilseyar
Kosiorek, Heidi E
Calcinotto, Arianna
Riggs, Daniel L
Keane, Niamh
Ahmann, Gregory J
Morrison, Kevin M
Fonseca, Rafael
Lacy, Martha Q
Dingli, David
Kumar, Shaji K
Ailawadhi, Sikander
Dispenzieri, Angela
Buadi, Francis
Gertz, Morie A
Reeder, Craig B
Lin, Yi
Chanan-Khan, Asher A
Stewart, A Keith
Fooksman, David
Bergsagel, P Leif http://orcid.org/0000-0003-1523-7388
Article History
Received: 30 August 2016
Accepted: 12 October 2016
First Online: 14 November 2016
Competing interests
: A.K.S. served as a consultant for Novartis. S.K.K. received research support from Novartis. The LCL161 clinical trial in MM patients was funded by Novartis.
Free to read: This content has been made available to all.